United States
Contact Us

BIO 2025

Big Ideas. Bold Voices.

Fresh thinking from the health practice at FINN Partners.

This year at BIO, the questions are bigger—and so are the stakes. From investor confidence to thought leadership, clinical trials to science advocacy, the way biotech companies communicate is more vital than ever.

That’s why we’ve gathered our top insights in one place—relevant reads to help biotech leaders navigate, influence, and lead with purpose.

Explore our latest
Communicate to Innovate: Five Communications Strategies Driving Biotech’s Future
Now More Than Ever: Why BioPharma Companies Must Live The Moral of Their Story
Investor Relations in a Biotech Downturn: Why Silence Is Not a Strategy – It’s a Risk
Inside BIO: Ron Cohen, MD on leading through uncertainty and championing biotech’s Future
For Leaders, When Is It Time to Speak Out for Science?
  • Explore our latest

    For Leaders, When Is It Time to Speak Out for Science?

    By: John Bianchi

    View Article

Good Medicine and Good Business – Why Biotech Must Stand Behind Newborn Testing
  • Explore our latest

    Good Medicine and Good Business – Why Biotech Must Stand Behind Newborn Testing

    By: Deborah Hernandez

For Biopharma in an AI-Driven World, Thought Leadership is the New Power Currency
  • Explore our latest

    For Biopharma in an AI-Driven World, Thought Leadership is the New Power Currency

    By: Arielle Bernstein Pinsof, MPP, Sr. Partner

    READ MORE

Let’s shape the future—together.

Get more insights and and connect with FINN Partners’ health practice.